Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab
Pediatric pharmacology · 2016
DOI: 10.15690/pf.v13i4.1615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric pharmacology, 2016. Verfasst von T. V. Sleptsova und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
научный биометрический журнал, который знакомит читателя с клиническими рекомендациями и особенностями применения лекарственных и вакцинных средств у детей, предоставляет исчерпывающую информацию о воздействии лекарственных средств на плод, о проводимых в
Zitieren
APA
Sleptsova, T. V., Alexeeva, E. I., Savostyanov, K. V., Pushkov, A. A., Bzarova, T. M., Isaeva, K. B., & Denisova, R. V. (2016). Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab. Pediatric pharmacology. https://doi.org/10.15690/pf.v13i4.1615
Vancouver
Sleptsova TV, Alexeeva EI, Savostyanov KV, Pushkov AA, Bzarova TM, Isaeva KB, et al. Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab. Pediatric pharmacology. 2016. doi:10.15690/pf.v13i4.1615
BibTeX
@article{Sleptsova2016,
author = {Sleptsova, T. V. and Alexeeva, E. I. and Savostyanov, K. V. and Pushkov, A. A. and Bzarova, T. M. and Isaeva, K. B. and Denisova, R. V.},
title = {Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab},
journal = {Pediatric pharmacology},
year = {2016},
doi = {10.15690/pf.v13i4.1615}
}
EUVIMED